Citigroup Inc Pfizer Inc Transaction History

Citigroup Inc

$150 Billion
Q1 2024

A detailed history of Citigroup Inc transactions in Pfizer Inc stock. As of the latest transaction made, Citigroup Inc holds 6,359,640 shares of PFE stock, worth $178 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

6,359,640

Previous 6,308,550 0.81%

Holding current value

$178 Million

Previous $182 Million 2.83%

% of portfolio

0.12%

Previous 0.13%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$25.89 - $29.73 $1.32 Million - $1.52 Million	51,090 Added 0.81%	6,359,640 $176 Million
Q4 2023 Feb 09, 2024	BUY	$26.13 - $33.94 $41.3 Million - $53.7 Million	1,580,936 Added 33.44%	6,308,550 $182 Million
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $3.72 Million - $4.35 Million	-115,946 Reduced 2.39%	4,727,614 $157 Million
Q2 2023 Aug 10, 2023	BUY	$36.12 - $41.79 $16.1 Million - $18.6 Million	445,528 Added 10.13%	4,843,560 $178 Million
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $29.9 Million - $39 Million	-759,913 Reduced 14.73%	4,398,032 $179 Million

Q4 2022 Feb 09, 2023	BUY	$41.75 - $54.5 $11.9 Million - $15.6 Million	285,485 Added 5.86%	5,157,945 $264 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $19.8 Million - $24.2 Million	453,462 Added 10.26%	4,872,460 $213 Million
Q2 2022 Aug 10, 2022	SELL	$46.53 - $55.17 $40.2 Million - $47.7 Million	-864,610 Reduced 16.36%	4,418,998 $232 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $59.6 Million - $73.9 Million	1,303,492 Added 32.75%	5,283,608 $274 Million
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $23.6 Million - $34.9 Million	-570,588 Reduced 12.54%	3,980,116 $235 Million
Q3 2021 Nov 10, 2021	BUY	$39.25 - $50.42 $179 Million - $229 Million	4,550,704 New	4,550,704 $196 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account